Vanda Pharmaceuticals (VNDA) Revenue (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.61% |
| Dec 31, 2025 | 1.70% |
| Sep 30, 2025 | 6.97% |
| Jun 30, 2025 | 5.09% |
| Mar 31, 2025 | -5.91% |
| Dec 31, 2024 | 11.61% |
| Sep 30, 2024 | -5.59% |
| Jun 30, 2024 | 6.35% |
| Mar 31, 2024 | 4.84% |
| Dec 31, 2023 | 16.63% |
| Sep 30, 2023 | -15.72% |
| Jun 30, 2023 | -26.31% |
| Mar 31, 2023 | -3.08% |
| Dec 31, 2022 | -1.28% |
| Sep 30, 2022 | 1.44% |
| Jun 30, 2022 | 6.97% |
| Mar 31, 2022 | -11.51% |
| Dec 31, 2021 | -2.96% |
| Sep 30, 2021 | 3.23% |
| Jun 30, 2021 | 8.35% |
| Mar 31, 2021 | -7.37% |
| Dec 31, 2020 | 12.18% |
| Sep 30, 2020 | -3.05% |
| Jun 30, 2020 | 7.25% |
| Mar 31, 2020 | -4.81% |
| Dec 31, 2019 | 2.43% |
| Sep 30, 2019 | 0.72% |
| Jun 30, 2019 | 23.78% |
| Mar 31, 2019 | -10.05% |
| Dec 31, 2018 | 7.95% |
| Sep 30, 2018 | 3.77% |
| Jun 30, 2018 | 8.62% |
| Mar 31, 2018 | -1.54% |
| Dec 31, 2017 | 7.11% |
| Sep 30, 2017 | -1.71% |
| Jun 30, 2017 | 12.40% |
| Mar 31, 2017 | -2.17% |
| Dec 31, 2016 | -0.62% |
| Sep 30, 2016 | 6.81% |
| Jun 30, 2016 | 8.32% |
| Mar 31, 2016 | 4.44% |
| Dec 31, 2015 | 12.37% |
| Sep 30, 2015 | 2.76% |
| Jun 30, 2015 | 24.52% |
| Mar 31, 2015 | 44.11% |
| Dec 31, 2014 | 3.98% |
| Sep 30, 2014 | 36.09% |
| Jun 30, 2014 | 18.80% |
| Mar 31, 2014 | 4.10% |
| Dec 31, 2013 | 0.85% |
| Sep 30, 2013 | 4.69% |
| Jun 30, 2013 | 3.11% |
| Mar 31, 2013 | 1.87% |
| Dec 31, 2012 | -4.44% |
| Sep 30, 2012 | -1.07% |
| Jun 30, 2012 | 2.91% |
| Mar 31, 2012 | -2.74% |
| Dec 31, 2011 | 5.03% |
| Sep 30, 2011 | 7.25% |
| Jun 30, 2011 | -0.95% |
| Mar 31, 2011 | 256.24% |
| Dec 31, 2010 | -166.26% |
| Sep 30, 2010 | 369.91% |